A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Feb 24, 2023

Keywords

ClinConnect Summary

Subjects who are willing to participate in a novel treatment for Revian Red All LED cap will be enrolled in this study. The cap uses two wavelengths of light, 620 nm and 660 nm. A study cap will be provided for each subject. Subjects will use the cap once daily, 10-minute treatment regimen which is the current androgenetic alopecia recommendation. The subjects will use the cap for a total of 6 months. To use the cap, subjects will connect the Revian Red All LED cap to a Smart App on a mobile phone device using Bluetooth. Subjects can use the Smart App to set daily reminders to use the cap, ...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women who are between the age of eighteen years and sixty-five years
• • Biopsy-proven diagnosis of CCCA Stage II-IV.
• • Must be on stable treatment without changes (on doxycycline, topical steroids, minoxidil and/or post 8 rounds of intralesional steroids) for at least 3 months
• Exclusion Criteria:
• • Subjects with other forms of hair loss that is not CCCA
• • Prior treatment with light source for alopecia
• • Males are excluded from this study since the prevalence of CCCA in males is so significantly low that it is difficult to find cases in a clinical setting